WallStreetZenWallStreetZen

NASDAQ: MYGN
Myriad Genetics Inc Stock Ownership - Who owns Myriad Genetics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Myriad Genetics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dale MuzzeyChief Scientific Officer2025-01-01417$13.71
$5.72kSell
Samraat S. RahaChief Operating Officer2024-12-1129,578$14.51
$429.18kSell
Samraat S. RahaChief Operating Officer2024-11-301,118$13.83
$15.46kBuy
Paul J. DiazPresident and CEO2024-10-1115,000$22.93
$343.95kSell
Dale MuzzeyChief Scientific Officer2024-10-09452$24.37
$11.02kSell
Mark VerrattiChief Commercial Officer2024-10-093,359$24.37
$81.86kSell
Mark VerrattiChief Commercial Officer2024-10-095,004$24.37
$121.95kSell
Kevin Richard HaasChief Technology Officer2024-10-092,515$24.37
$61.29kSell
Natalie MunkChief Accounting Officer2024-09-21964$27.64
$26.64kSell
Margaret AnconaSVP Chief of Staff2024-09-21966$27.64
$26.70kSell

1 of 6

MYGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MYGN insiders and whales buy or sell their stock.

MYGN Shareholders

What type of owners hold Myriad Genetics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc 116.96%15,442,339$197.04MInstitution
Blackrock Inc16.96%15,442,339$197.04MInstitution
Vanguard Group Inc11.33%10,311,664$131.58MInstitution
Wellington Management Group LLP7.38%6,716,583$85.70MInstitution
Millennium Management LLC5.69%5,176,511$66.05MInstitution
State Street Corp5.17%4,703,442$60.02MInstitution
Earnest Partners LLC4.35%3,955,948$50.48MInstitution
Camber Capital Management LP4.34%3,950,000$50.40MInstitution
Bank Of America Corp3.18%2,898,619$36.99MInstitution
Disciplined Growth Investors Inc2.78%2,527,435$32.25MInstitution

1 of 3

MYGN vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MYGN92.63%7.37%Net SellingNet Selling
CDNA77.74%22.26%Net SellingNet Selling
OPK19.10%80.90%Net BuyingNet Buying
GRAL65.05%28.57%Net BuyingNet Selling
CSTL85.18%14.82%Net SellingNet Selling
View Top Diagnostic & Research Stocks

Myriad Genetics Stock Ownership FAQ

Who owns Myriad Genetics?

Myriad Genetics (NASDAQ: MYGN) is owned by 99.66% institutional shareholders, 7.93% Myriad Genetics insiders, and 0.00% retail investors. Paul J. Diaz is the largest individual Myriad Genetics shareholder, owning 962,378.00 shares representing 1.06% of the company. Paul J. Diaz's Myriad Genetics shares are currently valued at $12.28M.

If you're new to stock investing, here's how to buy Myriad Genetics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.